Joshua Miles

441 total citations
14 papers, 320 citations indexed

About

Joshua Miles is a scholar working on Surgery, Cellular and Molecular Neuroscience and Oncology. According to data from OpenAlex, Joshua Miles has authored 14 papers receiving a total of 320 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Surgery, 3 papers in Cellular and Molecular Neuroscience and 3 papers in Oncology. Recurrent topics in Joshua Miles's work include Lipoproteins and Cardiovascular Health (8 papers), Hereditary Neurological Disorders (3 papers) and Pharmaceutical Economics and Policy (3 papers). Joshua Miles is often cited by papers focused on Lipoproteins and Cardiovascular Health (8 papers), Hereditary Neurological Disorders (3 papers) and Pharmaceutical Economics and Policy (3 papers). Joshua Miles collaborates with scholars based in United States, Canada and Australia. Joshua Miles's co-authors include Sergio Fazio, Hagai Tavori, Michael D. Shapiro, Deanna L. Plubell, Rachel M. DeVay, Liang Hong, Ilaria Giunzioni, Bruce A. Warden, MacRae F. Linton and Shirya Rashid and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Neuroscience and SHILAP Revista de lepidopterología.

In The Last Decade

Joshua Miles

13 papers receiving 319 citations

Peers

Joshua Miles

SURGE

IMMUN

CMN

Martin M. Bjørklund Denmark

Rachele Busca Switzerland

Sumihiko Hagita Japan

Anitra C. Wolf United States

Ragnar O. Vilmundarson Canada

Rupert Faraway United Kingdom

Youmin Zhang United States

Alberto Del Río-Espínola Spain

Editha Andres Saudi Arabia

Bandish Kapadia United States

Martin M. Bjørklund Denmark

Joshua Miles

84 ×0.4

SURGE

6 ×0.1

91 ×1.4

117 ×1.9

IMMUN

18 ×0.4

CMN

Citations per year, relative to Joshua Miles Joshua Miles (= 1×) peers Martin M. Bjørklund

Countries citing papers authored by Joshua Miles

Since Specialization

Citations

This map shows the geographic impact of Joshua Miles's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joshua Miles with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joshua Miles more than expected).

Fields of papers citing papers by Joshua Miles

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joshua Miles. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joshua Miles. The network helps show where Joshua Miles may publish in the future.

Co-authorship network of co-authors of Joshua Miles

This figure shows the co-authorship network connecting the top 25 collaborators of Joshua Miles. A scholar is included among the top collaborators of Joshua Miles based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joshua Miles. Joshua Miles is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Pacheco-Velázquez, Silvia Cecilia, Carlota Oleaga, Bastian Ramms, et al.. (2025). LDL-Bound PCSK9 Has a Slower Clearance Kinetic and Higher Use for HSPGs Than Free-PCSK9—Brief Report. Arteriosclerosis Thrombosis and Vascular Biology. 45(9). 1565–1573. 1 indexed citations

Kumari, Sneha, Joshua Miles, Yalini H. Wijesundara, et al.. (2024). Testing the Antigenic Potential of Transmembrane Proteins To Develop a Thermostable Tuberculosis MOF-Liposomal Vaccine. ACS Infectious Diseases. 11(1). 204–215.

Mahmood, Tahir, Joshua Miles, Jessica Minnier, et al.. (2023). Effect of PCSK9 inhibition on plasma levels of small dense low density lipoprotein-cholesterol and 7-ketocholesterol. Journal of clinical lipidology. 18(1). e50–e58. 5 indexed citations

Miles, Joshua, et al.. (2022). Prevalence and associated risk factors of chronic kidney disease: A case study within SIME clinics in Quito, Ecuador 2019–2021. Frontiers in Medicine. 9. 908551–908551. 2 indexed citations

Oleaga, Carlota, Michael D. Shapiro, Joshua Hay, et al.. (2021). Hepatic Sensing Loop Regulates PCSK9 Secretion in Response to Inhibitory Antibodies. Journal of the American College of Cardiology. 78(14). 1437–1449. 20 indexed citations

Velho, Tarciso, Peter V. Lovell, Samantha R. Friedrich, et al.. (2021). Divergent low-density lipoprotein receptor (LDLR) linked to low VSV G-dependent viral infectivity and unique serum lipid profile in zebra finches. Proceedings of the National Academy of Sciences. 118(18). 7 indexed citations

Warden, Bruce A., Joshua Miles, Carlota Oleaga, et al.. (2020). Unusual responses to PCSK9 inhibitors in a clinical cohort utilizing a structured follow-up protocol. SHILAP Revista de lepidopterología. 1. 100012–100012. 14 indexed citations

Zhou, Ye, David Borchelt, Sergio Fazio, et al.. (2020). Subcellular diversion of cholesterol by gain‐ and loss‐of‐function mutations in PMP22. Glia. 68(11). 2300–2315. 14 indexed citations

Tavori, Hagai, Alexandra M Fenton, Deanna L. Plubell, et al.. (2019). Elevated Lipoprotein(a) Levels Lower ABCA1 Cholesterol Efflux Capacity. The Journal of Clinical Endocrinology & Metabolism. 104(10). 4793–4803. 13 indexed citations

10.

Zhou, Ye, et al.. (2019). A neutral lipid-enriched diet improves myelination and alleviates peripheral nerve pathology in neuropathic mice. Experimental Neurology. 321. 113031–113031. 23 indexed citations

11.

Zhou, Ye, Joshua Miles, Hagai Tavori, et al.. (2019). PMP22 Regulates Cholesterol Trafficking and ABCA1-Mediated Cholesterol Efflux. Journal of Neuroscience. 39(27). 5404–5418. 32 indexed citations

12.

Warden, Bruce A., Jessica Minnier, Joshua Miles, et al.. (2019). Application of PCSK9 Inhibitors in Practice. Circulation Research. 124(1). 32–37. 52 indexed citations

13.

Shapiro, Michael D., Joshua Miles, Hagai Tavori, & Sergio Fazio. (2017). Diagnosing Resistance to a Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor. Annals of Internal Medicine. 168(5). 376–379. 43 indexed citations

14.

Tavori, Hagai, Ilaria Giunzioni, Irene M. Predazzi, et al.. (2016). Human PCSK9 promotes hepatic lipogenesis and atherosclerosis development via apoE- and LDLR-mediated mechanisms. Cardiovascular Research. 110(2). 268–278. 94 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact